Prevalence of Erectile Dysfunction in Men Screened for Prostate Cancer

Urology

Volumn 74, Issue 1, 2009, Pages 89-93

  Bianco Jr , Fernando J ^a   McHone, Benjamin R ^a   Wagner, Kristopher ^a   King, Andre ^a   Burgess, Jacqueline ^a   Patierno, Steve ^a   Jarrett, Thomas W ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER SCREENING; CONTROLLED STUDY; DIGITAL RECTAL EXAMINATION; ERECTILE DYSFUNCTION; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PHYSICIAN; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE; SCORING SYSTEM; SEXUAL HEALTH; UNITED STATES;

AGED; CROSS-SECTIONAL STUDIES; DISTRICT OF COLUMBIA; ERECTILE DYSFUNCTION; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 67649158706     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2008.03.036     Document Type: Article

References (18)

1. NIH Consensus Development Panel on Impotence. NIH consensus conference: Impotence. JAMA 270 (1993) 83-90
2. Min J.K., Williams K.A., Okwuso T.M., et al. Prediction of coronary heart disease by erectile dysfunction in men referred for nuclear stress testing. Arch Intern Med 166 (2006) 201-206
3. Saigal C.S., Wessells H., Pace J., et al. Predictors and prevalence of erectile dysfunction in a racially diverse population. Arch Intern Med 166 (2006) 207-212
4. Selvin E., Burnett A.L., and Platz E.A. Prevalence and risk factors for erectile dysfunction in the US. Am J Med 120 (2007) 151-157
5. Grover S.A., Lowensteyn I., Kaouache M., et al. The prevalence of erectile dysfunction in the primary care setting. Arch Intern Med 166 (2006) 213-219
6. Rosen R.C., Riley A., Wagner G., et al. The International Index of Erectile Function (IIEF): A multidimensional scale for the assessment of erectile dysfunction. Urology 49 (1997) 822-830
7. Rosen R.C., Cappelleri J., Smith M.D., et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 11 (1999) 319-326
8. American Cancer Society. Cancer facts and figures. http://www.cancer.org/docroot/STT/content/STT_1x_Cancer_Facts_Figures_2007.asp Accessed November 25, 2007
9. Bartsch G., Horninger W., Klocker H., et al. Urology 58 (2001) 417-424
10. American Cancer Society. How is cancer found. http://www.cancer.org/docroot/CRI/content/CRI_2_2_3X_How_is_prostate_cancer_found_36.asp?sitearea= Accessed November 25, 2007
11. Feldman H.A., Goldstein I., Hatzichristou D.G., et al. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 151 (1994) 54-61
12. Hoffman R.M., Gilliland F.D., Eley J.M., et al. Racial and ethnic differences in advanced-stage prostate cancer-The Prostate Cancer Outcomes Study. J Natl Cancer Inst 93 (2001) 388-395
13. Polednak A.P., and Flannery J. Black versus white racial differences in clinical stage at diagnosis and treatment of prostate cancer in Connecticut. Cancer 70 (1992) 2152-2158
14. Barqawi A., O'Donnell C., Kumar R., et al. Correlation between LUTS (AUS-SS) and erectile dysfunction (SHIM) in an age-matched racially diverse male population: Data from the Prostate Cancer Awareness Week (PCAW). Int J Impot Res 17 (2005) 370-374
15. Araujo A.B., Mohr B.A., and McKinlay J.B. Changes in sexual function in middle-aged and older men: Longitudinal data from the Massachusetts Male Aging Study. J Am Geriatr Soc 52 (2004) 1502-1509
16. Potosky A.L., Davis W.W., Hoffman R.M., et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: The Prostate Cancer Outcomes Study. J Natl Cancer Inst 96 (2004) 1358-1367
17. Sirovich B.E., Schwartz L.M., and Woloshin S. Screening men for prostate and colorectal cancer in the United States: Does practice reflect the evidence?. JAMA 289 (2003) 1414-1420
18. Porok P.C., Andriole G.L., Bresalier R.S., et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial. Control Clin Trials 21 (2000) 273S-309S